You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 5, 2026

Profile for Uruguay Patent: 32174


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Uruguay Patent: 32174

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Jun 20, 2030 Entasis Therap NUZOLVENCE zoliflodacin
⤷  Start Trial Oct 13, 2029 Entasis Therap NUZOLVENCE zoliflodacin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Uruguayan Patent UY32174: Scope, Claims, and Patent Landscape Analysis

Last updated: March 9, 2026

What is the scope of patent UY32174?

Patent UY32174 pertains to a pharmaceutical invention with specified claims that define its legal protection. The patent claims broadly cover a specific compound, formulation, or therapeutic use, depending on the original patent application. The scope appears to focus on a new chemical entity, a novel formulation, or a specific method of treatment, based on the patent documentation.

In the available patent documentation, the scope can be summarized as follows:

  • Chemical Composition: Covers a novel chemical compound or a specific combination of compounds.
  • Pharmacological Use: Protects a particular therapeutic use, such as treating a specific disease or condition.
  • Formulation and Dosage: Encompasses a new pharmaceutical formulation, including stabilities and delivery mechanisms.
  • Method of Manufacturing: Claims may include processes for synthesizing or preparing the compound or formulation.

The detailed claims section would specify the boundaries, often comprising independent and dependent claims that narrow or specify aspects of the invention.

What are the key claims of UY32174?

A typical patent in this field includes:

  • Independent Claims: Broadest scope; define the novel compound or method.

  • Dependent Claims: Narrower; specify additional features such as specific substituents, salts, or use cases.

Without the exact claim text, an outline based on common practice suggests:

Claim Type Content Scope
Independent Claim A pharmaceutical compound having the chemical structure X or its salt Broad; covers the core molecule
Dependent Claim The compound of claim 1, wherein the substituents are ... Adds specific chemical features
Use Claim Use of the compound in treating disease Y Protects therapeutic application
Formulation Claim A pharmaceutical formulation comprising the compound Protects delivery forms

The claims aim to secure protection over the core compound, its salts, pharmaceutical compositions, and therapeutic methods, which is typical in drug patents.

How does the patent landscape for Uruguay look in this area?

The patent landscape in Uruguay for pharmaceutical compounds is characterized by limited local filings. Due to Uruguay's small market size, patent activity tends to originate from international innovators filing via patent cooperation treaties (PCT) or national phase entries.

Key aspects of the patent landscape:

  • International Patent Families: Filings in Uruguay are often part of broader international patent portfolios, with applications filed through mechanisms like PCT.

  • Regional and Global Filings: Innovators prioritize filings in major markets (U.S., Europe, Japan, China), then extend to Uruguay for market-specific protection or to establish local rights.

  • Technology Focus: The landscape is concentrated around small molecules, biologics, and formulations targeting prevalent diseases such as cancer, infectious diseases, and chronic illnesses.

  • Patent Erosion Factors: Uruguay’s patent term is 20 years from the filing date, with limited or no additional patent term extensions available for drugs.

  • Legal Environment: Uruguay's patent law aligns with international standards, with potential for patents to be challenged under national law or through trade secret strategies.

Major patent filers in Uruguay in this area tend to align with those holding large international portfolios, such as multinational pharmaceutical companies. Local filings are rare and primarily rely on foreign patent rights.

Comparative analysis of patent claims scope in similar patents

Patent Country Claim Scope Innovation Type Patent Term
US 10,XXXX,XXX (hypothetical) US Broad compound claims, multiple therapeutic uses Small molecule 20 years
EP 2,XXXXX (hypothetical) Europe Formulations with specific excipients Drug delivery 20 years
Int. application WO 20XXXXXX PCT Composition and use for specific diseases Combination therapy 20 years from earliest priority

The scope typically narrows during examination to avoid overlap with prior art, but core claims on a new chemical entity or therapeutic use tend to remain broad unless specific prior art limits them.

Key considerations for patent strategy in Uruguay

  • Broad Claims Freedom: Due to the limited local patent landscape, broad claims aligned with international filings can be crucial to ensure robust protection.

  • Local Enforcement: Patents are enforceable in Uruguay, but enforcement efficacy varies; therefore, securing patents in larger markets is essential for global protection.

  • Patent Term Planning: Given Uruguay’s patent term, early filings and strategic extensions (via patent term extensions if available) should be considered.

  • Patent Challenges: Expect potential opposition or invalidation attempts from competitors, especially if claims lack novelty or inventive step over regional prior art.

Summary of Regulatory and Patent Integration

Uruguayan drug patents often align with local regulatory approvals. Securing patent protection prior to regulatory approval can prevent generic entry, which in Uruguay typically occurs post-patent expiration if no extension is applicable.

Conclusion

Patent UY32174 offers initial protection within Uruguay for a specific pharmaceutical invention, likely covering a novel chemical compound, formulation, or use. While Uruguay's patent landscape is limited, international patent strategies are critical for global exclusivity. The patent claims appear to be structured to cover both structural and therapeutic aspects, providing robust protection if supported by thorough prior art searches and claim drafting.

Key Takeaways

  • UY32174 likely covers a specific chemical entity, formulation, or therapeutic use, with claims strategically broad to maximize protection.
  • The patent landscape in Uruguay is limited, driven by international filings; local activity remains sparse.
  • Patent strategies should emphasize broad claims aligned with international protections, considering local enforcement dynamics.
  • Uruguay’s patent law offers 20-year protection, with no significant extensions, making early filings critical.
  • Patent challenges are possible; claims must demonstrate novelty and inventive step to withstand future scrutiny.

FAQs

  1. What type of claims does UY32174 contain?
    It likely includes independent claims on the chemical compound or formulation, and dependent claims on specific features, uses, or methods.

  2. Are patents in Uruguay enforceable internationally?
    No. Each patent is country-specific; protection needs to be sought in each jurisdiction where enforcement is desired.

  3. How does Uruguay's patent law compare to major markets?
    It aligns with international standards but offers limited or no patent term extensions; enforcement capacity varies.

  4. Can a patent filed in Uruguay prevent others from manufacturing the same drug?
    Yes, if the patent is valid and upheld, it can prevent third-party manufacturing and sales within Uruguay.

  5. Is local patent filing necessary for drug marketing approval?
    Not strictly, but patent filing can prevent generic competition and provide exclusivity during regulatory approval.


References

[1] Uruguay Patent Law, Ley No. 17.611.
[2] World Intellectual Property Organization. Patent Cooperation Treaty.
[3] World Trade Organization. Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
[4] Espacenet Patent Database.
[5] Uruguayan National Directorate of Industrial Property. Patent Search Resources.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.